REGENXBIO Inc. SEC filings RGNX

REGENXBIO Inc. has 805 filings in SEC EDGAR's recent list, going back to Nov 7, 2013. Its latest annual report, Form ARS, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

REGENXBIO Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change
Oct 16, 2026 Oct 14, 2026
8-K Current report
Material agreement
Sep 23, 2026 Sep 23, 2026
8-K Current report
Officer or director change
Aug 25, 2026 Aug 25, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 24, 2026 Aug 24, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Other events
Jul 20, 2026 Jul 16, 2026
424B5 Prospectus supplement Jul 17, 2026 —
FWP Free writing prospectus Jul 17, 2026 —
424B5 Prospectus supplement Jul 16, 2026 —
SC TO-I/A Filing Jul 6, 2026 —
SC TO-I/A Filing Jul 1, 2026 —
8-K Current report
Other events
Jun 29, 2026 Jun 23, 2026
SC TO-I Filing Jun 3, 2026 —
8-K Current report
Shareholder vote results, Other events
Jun 3, 2026 May 29, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 14, 2026 May 14, 2026
ARS Annual report to shareholders Apr 14, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 14, 2026 —
DEF 14A Proxy statement Apr 14, 2026 May 29, 2026
PRE 14A Preliminary proxy statement Apr 3, 2026 May 29, 2026
8-K Current report
Material agreement
Mar 20, 2026 Mar 18, 2026
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
424B5 Prospectus supplement Feb 12, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Feb 10, 2026 Feb 7, 2026
8-K Current report
Other events
Jan 28, 2026 Jan 23, 2026
EFFECT Filing Dec 12, 2025 —
CORRESP Letter to the SEC Dec 9, 2025 —
S-3 Shelf registration Nov 26, 2025 —
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 5, 2025
EFFECT Filing Jun 25, 2025 —
424B3 Prospectus Jun 25, 2025 —
CORRESP Letter to the SEC Jun 23, 2025 —
UPLOAD Letter from the SEC Jun 20, 2025 —
S-3 Shelf registration Jun 13, 2025 —
S-8 Employee stock plan registration Jun 13, 2025 —
8-K Current report
Shareholder vote results
Jun 3, 2025 May 30, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
May 19, 2025 May 16, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
EFFECT Filing Apr 14, 2025 —
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 May 30, 2025
S-8 Employee stock plan registration Mar 13, 2025 —
POS AM Filing Mar 13, 2025 —
10-K Annual report Mar 13, 2025 Dec 31, 2024
POSASR Filing Mar 13, 2025 —
8-K Current report
Results of operations
Mar 13, 2025 Mar 13, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 4, 2025 Mar 3, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
424B5 Prospectus supplement Dec 9, 2024 —
8-K Current report
Other events
Dec 9, 2024 Dec 9, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 17, 2024 Sep 16, 2024
8-K Current report
Officer or director change
Aug 6, 2024 Aug 1, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 13, 2024 Jun 12, 2024
8-K Current report
Shareholder vote results
Jun 3, 2024 May 31, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 4, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 4, 2024 —
DEF 14A Proxy statement Apr 4, 2024 May 31, 2024
8-K Current report
Other events
Mar 11, 2024 Mar 6, 2024
424B5 Prospectus supplement Mar 8, 2024 —
FWP Free writing prospectus Mar 7, 2024 —
424B5 Prospectus supplement Mar 6, 2024 —
S-8 Employee stock plan registration Feb 27, 2024 —
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
424B5 Prospectus supplement Sep 1, 2023 —
8-K Current report
Other events
Sep 1, 2023 Sep 1, 2023
S-3ASR Automatic shelf registration Aug 4, 2023 —
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Shareholder vote results
Jun 5, 2023 Jun 2, 2023
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
ARS Annual report to shareholders Apr 6, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 6, 2023 —
DEF 14A Proxy statement Apr 6, 2023 —
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Officer or director change
Jan 10, 2023 Jan 9, 2023
S-3ASR Automatic shelf registration Dec 30, 2022 —
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Officer or director change, Shareholder vote results
Jun 7, 2022 Jun 3, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 7, 2022 —
DEF 14A Proxy statement Apr 7, 2022 Jun 3, 2022
8-K Current report
Material agreement
Mar 25, 2022 Mar 21, 2022
8-K Current report
Officer or director change
Mar 18, 2022 Mar 14, 2022
S-8 Employee stock plan registration Mar 1, 2022 —
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
8-K Current report
Regulation FD disclosure, Other events
Feb 14, 2022 Feb 12, 2022
8-K Current report
Regulation FD disclosure, Other events
Feb 9, 2022 Feb 9, 2022
8-K Current report
Material agreement
Nov 15, 2021 Nov 12, 2021
8-K Current report
Regulation FD disclosure, Other events
Nov 12, 2021 Nov 12, 2021
8-K Current report
Regulation FD disclosure, Other events
Nov 9, 2021 Nov 8, 2021
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
8-K Current report
Regulation FD disclosure, Other events
Oct 12, 2021 Oct 9, 2021
8-K Current report
Regulation FD disclosure, Other events
Oct 1, 2021 Oct 1, 2021
8-K Current report
Material agreement, Regulation FD disclosure
Sep 13, 2021 Sep 10, 2021
8-K Current report
Officer or director change
Sep 7, 2021 Sep 3, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Other events
Jul 16, 2021 Jul 13, 2021
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 7, 2021 Jun 4, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
DEFA14A Additional proxy material Apr 19, 2021 —
DEF 14A Proxy statement Apr 19, 2021 Jun 4, 2021
PRE 14A Preliminary proxy statement Apr 8, 2021 Jun 4, 2021
SEC STAFF LETTER Filing Mar 29, 2021 —
S-8 Employee stock plan registration Mar 1, 2021 —
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 1, 2021 Mar 1, 2021
SEC STAFF LETTER Filing Mar 1, 2021 —
8-K Current report
Other events
Jan 8, 2021 Jan 7, 2021
424B5 Prospectus supplement Jan 8, 2021 —
424B5 Prospectus supplement Jan 6, 2021 —
8-K Current report
Results of operations, Other events
Jan 5, 2021 Jan 5, 2021
8-K Current report
Material agreement, New debt
Dec 22, 2020 Dec 22, 2020
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
8-K Current report
Other events
Oct 27, 2020 Oct 27, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Officer or director change
Jul 2, 2020 Jun 29, 2020
8-K Current report
Shareholder vote results
Jun 1, 2020 May 29, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 8, 2020 —
DEF 14A Proxy statement Apr 8, 2020 May 29, 2020
S-8 Employee stock plan registration Feb 26, 2020 —
10-K Annual report Feb 26, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 26, 2020 Feb 26, 2020
8-K Current report
Results of operations, Other events
Jan 9, 2020 Jan 9, 2020
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K Current report
Regulation FD disclosure, Other events
Oct 15, 2019 Oct 11, 2019
SEC STAFF LETTER Filing Sep 30, 2019 —
SEC STAFF LETTER Filing Sep 23, 2019 —
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K Current report
Material agreement, Officer or director change, Shareholder vote results
Jun 3, 2019 May 28, 2019
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
DEFA14A Additional proxy material Apr 11, 2019 —
DEF 14A Proxy statement Apr 11, 2019 May 31, 2019
CT ORDER Filing Apr 3, 2019 —
S-8 Employee stock plan registration Feb 27, 2019 —
10-K Annual report Feb 27, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 27, 2019 Feb 27, 2019
8-K Current report
Results of operations, Other events
Jan 3, 2019 Jan 3, 2019
10-Q Quarterly report Nov 7, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 7, 2018 Nov 7, 2018
8-K Current report
Material agreement, Regulation FD disclosure
Nov 6, 2018 Nov 4, 2018
8-K Current report
Regulation FD disclosure, Other events
Oct 29, 2018 Oct 26, 2018
8-K Current report
Other events
Aug 10, 2018 Aug 9, 2018
424B5 Prospectus supplement Aug 10, 2018 —
RW Filing Aug 9, 2018 —
424B5 Prospectus supplement Aug 8, 2018 —
S-3ASR Automatic shelf registration Aug 8, 2018 —
S-3 Shelf registration Aug 8, 2018 —
10-Q Quarterly report Aug 8, 2018 Jun 30, 2018
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2018 Aug 8, 2018
8-K Current report
Other events
Jun 11, 2018 Jun 8, 2018
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2018 May 25, 2018
CT ORDER Filing May 16, 2018 —
10-Q Quarterly report May 8, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 8, 2018 May 8, 2018
DEFA14A Additional proxy material Apr 12, 2018 —
DEF 14A Proxy statement Apr 12, 2018 May 25, 2018
S-8 Employee stock plan registration Mar 6, 2018 —
10-K Annual report Mar 6, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 6, 2018 Mar 6, 2018
8-K/A Amended current report
Officer or director change
Feb 1, 2018 Jan 5, 2018
8-K Current report
Officer or director change
Jan 11, 2018 Jan 5, 2018
8-K Current report
Material agreement, Regulation FD disclosure
Jan 9, 2018 Jan 8, 2018
8-K Current report
Results of operations, Other events
Jan 4, 2018 Jan 4, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
RGNX (Nasdaq)
Fiscal year ends
December 31
Headquarters
Rockville, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1590877
Former names
ReGenX Biosciences, LLC (until Nov 7, 2013)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.